Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Disability Diversity in Clinical Trials

- PMLiVE

FREE WEBINAR – Not Just a Number: Making Sure Every Voice Shapes the Future of Medicine – Origins & ISPEP

What Does Patient-focused Healthcare Really Mean? Healthcare is built around patients, but too often, their voices are an afterthought. Truly patient-focused medicine isn’t just about treatment - it’s about understanding...

Origins – The Patient Focused Specialists

- PMLiVE

REGISTER NOW – Not Just a Number: Making Sure Every Voice Shapes the Future of Medicine

Health Equity: Why Lived Experience Matters Medicine is constantly evolving, but progress is only meaningful if it reaches everyone. Health outcomes are shaped not just by science, but by social...

Origins – The Patient Focused Specialists

- PMLiVE

Hear From Her: Extraordinary Women Who Are Redefining Healthcare Leadership

That’s a wrap for Season 2 of Medscape Education’s Award-Winning Podcast Series, Hear From Her: Women in Healthcare Leadership! (Not to worry, Season 3 is just around the corner.)  And...

Medscape Education

Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics

Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics

Specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024–2025. Jump in as the Mtech Access experts give their hot take on each...

Petauri Evidence

- PMLiVE

Bristol Myers Squibb’s subcutaneous Opdivo shows promise in kidney cancer

More than 430,000 new cases of renal cell carcinoma are diagnosed globally every year

- PMLiVE

BMS announces CHMP recommendation for multiple myeloma therapy Abecma

More than 50,000 cases of the blood cancer are diagnosed in Europe every year

- PMLiVE

BMS, Exelixis and Ipsen announce positive four-year results for kidney cancer regimen

More than 430,000 new cases of renal cell carcinoma are diagnosed globally every year

- PMLiVE

BMS presents promising late-stage results for Opdivo plus Yervoy in colorectal cancer

More than 1.9 million cases of colorectal cancer were diagnosed globally in 2020

- PMLiVE

Bristol Myers Squibb’s Opdualag recommended by NICE for advanced melanoma

More than 16,700 new cases of melanoma are diagnosed in the UK every year

- PMLiVE

Bristol Myers Squibb to acquire radiopharmaceutical specialist RayzeBio for $4.1bn

The merger includes a candidate in phase 3 development for gastroenteropancreatic neuroendocrine tumours

- PMLiVE

Bristol Myers Squibb’s Opdualag approved by MHRA for advanced melanoma

Approximately 17,000 cases of melanoma are diagnosed in the UK every year

- PMLiVE

Bristol Myers Squibb’s Sotyktu accepted by SMC for plaque psoriasis

More than 133,520 people in Scotland are affected by the inflammatory condition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links